$290M Settlement Reached In Related Valeant Insider Trading Suits
SANTA ANA, Calif. — Defendants in a pair of related securities class action lawsuits alleging an insider-trading and front-running scheme regarding pharmaceutical company Valeant Pharmaceuticals International Inc.’s attempt at a hostile...To view the full article, register now.
Already a subscriber? Click here to view full article